Controlling matrix formation and cross-linking by hypoxia in cardiovascular tissue engineering

Area of Science:

• Biomedical Engineering
• Cell Biology
• Regenerative Medicine

Background:

• Cardiovascular tissue engineering requires robust extracellular matrix (ECM) development for in vivo functionality.
• Controlling ECM formation in vitro is essential for successful tissue-engineered constructs.

Purpose of the Study:

• To investigate the effect of low oxygen concentrations on ECM production by human vascular myofibroblasts.
• To determine if hypoxia stimulates the expression of key ECM components and related enzymes.

Main Methods:

• Human vascular myofibroblasts were cultured at varying oxygen concentrations (0.5% to 7% O(2)) for gene expression analysis.
• Key genes including VEGF, procollagen, elastin, LOX, and LH2 were measured.
• Protein synthesis of collagen and LH2 levels were assessed at different oxygen levels.

Main Results:

• Hypoxia (≤4% O(2)) induced hypoxia-driven gene expression, marked by increased VEGF.
• Procollagen α1(I) and α1(III) gene expression significantly increased at oxygen levels below 4%.
• Lysyl hydroxylase 2 (LH2) and lysyl oxidase (LOX) gene expression, as well as collagen synthesis and LH2 protein levels, were elevated at 2% O(2) and lower.

Conclusions:

• Oxygen concentrations below 4% enhance extracellular matrix production by human myofibroblasts.
• These findings offer a method for in vitro control of tissue development in cardiovascular tissue engineering.
• Culturing cells under low oxygen conditions can promote the formation of a well-developed ECM for engineered tissues.